Arovella Therapeutics Ltd. announced that Mr. Paul Hopper is stepping down from his role as Non-Executive Chairman on June 30, 2022. Non-Executive Director of Arovella, Dr Elizabeth Stoner will assume the role as interim Chairperson, while the company engages in a search for a replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.115 AUD | -4.17% | 0.00% | 0.00% |
03-26 | Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise | MT |
03-20 | Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 83.56M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ALA Stock
- News Arovella Therapeutics Limited
- Arovella Therapeutics Ltd Announces Executive Changes